Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Acne is an important sign of androgen excess disorders in women.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Hirsutism causes significant psychological distress in women.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Certain gene variations might be linked to severe acne in women but not in men.

Finasteride negatively affects fish reproduction and gonadal development.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.